ecancermedicalscience

Conference Report

Eurocan Platform meeting: European recommendations for biomarker-based chemoprevention trials

8 Dec 2014
Linda Cairns

Chemoprevention or the now more preferred ‘cancer prevention’ is the long-term administration of a biological or chemical agent to reduce the risk of cancer. This approach has long been active in individuals at high risk of developing breast or colon cancer. The aim of this expert meeting was to review the current status of the field of cancer prevention and potential, emerging biomarkers specifically focusing on breast, colon, and lung cancer but also with sessions on ovary and prostate.

Related Articles

Tushar Ambekar, Amey Oak, Sivaranjini Kannusamy, Sandhya Cheulkar, Riya R John, Shalmali Chavan, Saket Mendhe, Supriya Kadam, Mamta Lade, Ganesh Balasubramanium, Ashwin Desouza, Avanish Saklani, Rajesh Dikshit, Pankaj Chaturvedi, Sudeep Gupta
Joshua Agilinko, Sonam Patel, Jogitha Selvarajah, Nicholas Tekkis, Mathew Vithayathil, Suzette Samlalsingh
Adnan-Mustafiz Chowdhury, Sattam A Halaseh, Debora Joseph, Abel I Abel, Nikita Jha, Amro Al-Karadsheh, Hakam Al-Karadsheh, Omar A Salem, Sama F Salaitah, Noor M Arman, Georges Rizkallah
Intissar Belrhali, Ibrahim El Ghissassi, Boutaina Cherkaoui, Oumaima Lamsyah, Khaoula Ouchen, Soufiane Bel Rhali, Saoussane Kharmoum, Sarah Naciri, Hanane Inrhaoun, Siham Lkhoyaali, Salma Najm, Hind Mrabti, Hassan Errihani